Cancer–malaria: hidden connections
Open Access
- 31 October 2018
- journal article
- research article
- Published by The Royal Society in Open Biology
- Vol. 8 (10)
Abstract
Cancer and malaria exemplify two maladies historically assigned to separated research spaces. Cancer, on the one hand, ranks among the top priorities in the research agenda of developed countries. Its rise is mostly explained by the ageing of these populations and linked to environment and lifestyle. Malaria, on the other hand, represents a major health burden for developing countries in the Southern Hemisphere. These two diseases also belong to separate fields of medicine: non-communicable diseases for cancer and communicable diseases for malaria.Keywords
Funding Information
- Association pour la recherche en cancérologie de Saint-Cloud
- ADEBIOPHARM
This publication has 22 references indexed in Scilit:
- CD82/KAI1 Maintains the Dormancy of Long-Term Hematopoietic Stem Cells through Interaction with DARC-Expressing MacrophagesCell Stem Cell, 2016
- Host-based Prophylaxis Successfully Targets Liver Stage Malaria ParasitesMolecular Therapy, 2015
- Suppression of Host p53 Is Critical for Plasmodium Liver-Stage InfectionCell Reports, 2013
- A million africans a year dying from cancer by 2030: What can cancer research and control offer to the continent?International Journal of Cancer, 2011
- Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11gene expression in forming surface P-selectin ligands in aggressive breast cancer cellsBreast Cancer Research, 2011
- Chondroitin synthases I, II, III and chondroitin sulfate glucuronyltransferase expression in colorectal cancerMolecular Medicine Reports, 2011
- VAR2CSA Expression on the Surface of Placenta‐DerivedPlasmodium falciparum–Infected ErythrocytesThe Journal of Infectious Diseases, 2008
- How does Plasmodium falciparum stick to CSA? Let's see in the crystalNature Structural & Molecular Biology, 2008
- Chemokine Decoy Receptors: New Players in Reproductive ImmunologyImmunological Investigations, 2008
- Duffy‐null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood‐stage infectionFEBS Letters, 2001